Dentists are an integral part of the health care team, and play an essential role not only in the early detection of oral cancer, but also in the management of some systemic conditions. This course highlights the role of the dentist as part of the interprofessional health care team using specific examples as illustrations: from detection and management of oral pre-malignant conditions, complications of specific cancer therapies, to oral features of Sjögren’s syndrome.
- Better recognize oral precancers, improve diagnostic skills for oral leukoplakia, and work in collaboration with an interdisciplinary team to improve oral cancer outcomes via early detection
- Recognize and formulate a differential diagnosis for the most common oral and dental complications of cancer therapy, and become familiar with the management strategies of patients with these complications
- Provide a differential diagnosis for patients presenting with Sjögren's Syndrome (SS) and understand the role of the oral health care professional in the multidisciplinary team of providers managing patients with SS
- Formulate a differential diagnosis for oral leukoplakia and understand the etiology and management of oral dysplasias (Dr. Kyle Jones)
- Review the most common oral and dental complications of cancer therapy (Dr. Alessandro Villa)
- Understand the current classification criteria for Sjögren's Syndrome (2016 ACR-EULAR) and management strategies for patients with dry mouth (Dr. Caroline Shiboski)
This course is designed for general dentists, dental specialists, and the entire dental team.
Caroline Shiboski, DDS, MPH, PhD
Dr. Caroline Shiboski is the Leland A. and Gladys K. Barber Distinguished Professor in Dentistry, Professor of Oral Medicine, and Chair of the Department of Orofacial Sciences, School of Dentistry. She has advanced training in Oral Medicine (Diplomate of the American Board of Oral Medicine) and Epidemiology (MPH and PhD from UC Berkeley). Her research experience focuses on the epidemiology of oral manifestations related of immune dysfunction, Oral Cancer, and Sjögren’s syndrome.
Kyle Jones, DDS, PhD
Dr. Kyle Jones is an Assistant Professor in the UCSF School of Dentistry, Diplomate of the American Board of Oral and Maxillofacial Pathology, and Director of the UCSF Oral Dysplasia Program, which specializes in the diagnosis, management, and research of oral dysplasias. Dr. Jones obtained his DDS, PhD, and certificate in oral and maxillofacial pathology from UCSF. His current research focuses on oral dysplasia and head and neck cancer immunology, with the goal of improving existing immunotherapies for head and neck cancer patients. He is also interested in using state-of-the-art microscopy techniques to better understand the immune response to various oral diseases.
Alessandro Villa, DDS, PhD, MPH
Dr. Alessandro Villa is the Chief of the Sol Silverman Oral Medicine Clinic at UCSF where he also serves as program director for the Oral Medicine Residency program. Dr. Villa obtained his DDS and PhD in Italy and a certificate in oral medicine from Brigham and Women’s Hospital and Harvard School of Dental Medicine. He also served as a post-doctoral fellow at the National Cancer Institute. Dr. Villa’s research interests include the pathobiology of oral complications from cancer treatment and therapeutic strategies for oral leukoplakia. In addition, Dr. Villa is working to reduce the burden of HPV associated oropharyngeal cancers.
CDE Coursework Units:
2 Category I Units
Tuition refund, less a $25 cancellation fee, will be issued only for cancellations received in writing at least 3 business days prior to the start date of the course. No refunds will be issued for late cancellations or no-shows. We reserve the right to cancel any course due to circumstances beyond our control; under those circumstances we will refund all course fee payments. Please be aware that UCSF School of Dentistry CDE is not responsible for reimbursement of nonrefundable airline tickets or any other travel expenses in the event that a course is cancelled.